Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus
Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus
Not yet recruiting · NCT07373392 · Registry updated 2026-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus | Dyslipidemias, Hypercholesterolemia, Insulin Resistance, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, hyperlipidemia, immune system disorder, metabolic disease, prediabetes syndrome, type 1 diabetes mellitus, type 2 diabetes mellitus | Not yet recruiting | Not applicable | 2026-01-29 | NCT07373392 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aalborg University | 55 |
| ProBiotix Health Plc. | 1 |
| Steno Diabetes Center Nordjylland | 7 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Health Science and Technology, Aalborg University | Gistrup | Denmark | 1 |
| Steno Diabetes Center Nordjylland | Gistrup | Denmark | 2 |